$69.7 Billion Oral Solid Dosage Contract Manufacturing Market Assessment 2024-2034 Featuring Lonza Group, Catalent, Recipharm
13 mars 2024 12h00 HE
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global Oral Solid Dosage Contract Manufacturing Market by Product Type, by Mechanism, by End-User, and By Region" report has been added to ...
Global Oral Solid Dosage Contract Manufacturing Market 2024-2030: Regional Trends for Tablets, Capsules, Powders, and Granules
13 mars 2024 11h10 HE
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Tablets, Capsules, Powders,...
Cirtronics Highlights the Importance of Market Fit in Successful Commercialization through Panel Discussions at the 2023 & 2024 Robotics Summit and Expo
12 mars 2024 12h09 HE
|
Cirtronics
Milford, NH, March 12, 2024 (GLOBE NEWSWIRE) -- Through shared insights from four experts in the robotics industry during a panel discussion at the 2023 Robotics Summit and Expo in Boston, MA,...
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
06 mars 2024 23h58 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today the pricing...
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
06 mars 2024 16h32 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today that it...
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
06 mars 2024 16h31 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
28 févr. 2024 16h29 HE
|
Societal CDMO, Inc.
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to...
Global Aseptic Manufacturing Industry Report 2023: Biopharma Growth and Advanced Manufacturing Technologies Demand Fueling Opportunities - Forecasts to 2029
22 févr. 2024 10h34 HE
|
Research and Markets
Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Aseptic Manufacturing Market (2023 Edition): Analysis By Type (Isolators, RABS, Cleanroom Equipment), By Product Type, By Applications, By...
Global Biologics Contract Manufacturing Research Report 2022-2023 and 2023-2035: Biologics CMO Made Considerable Investments to Expand Facilities, With Some CMOs Re-evaluating Capacity Investments
20 févr. 2024 04h01 HE
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of...
CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine
15 févr. 2024 11h00 HE
|
Natural Alternatives International Inc
The new agreement strengthens brand expansion and distribution of a top selling ingredient in sports nutrition—CarnoSyn® beta-alanine.